移動互聯(中國)(01439.HK):清盤呈請將於2月8日聆訊
格隆匯1月12日丨移動互聯(中國)(01439.HK)公佈,於2022年10月24日,公司接獲由浩宸律師行有限法律責任合夥("呈請人")根據香港法例第32章《公司(清盤及雜項條文)條例》向香港特別行政區高等法院("高等法院")提呈對公司進行清盤命令的呈請("該呈請")。該呈請將於2023年2月8日上午十時三十分於高等法院進行聆訊。
該呈請乃針對公司無法償還金額為956,490.42港元之債務。公司正就該呈請尋求法律意見及與呈請人溝通,並將吿知其股東及投資者有關該呈請之任何重大進展,並將於適當時候根據上市規則另行刊發公佈。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.